TELLMEGEN Trademark

Trademark Overview


On Thursday, January 19, 2023, a trademark application was filed for TELLMEGEN with the United States Patent and Trademark Office. The USPTO has given the TELLMEGEN trademark a serial number of 97761526. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 2, 2024. This trademark is owned by GENELINK, S.L.. The TELLMEGEN trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Medical diagnostic apparatus for measuring genetic predisposition to diseases; Medical diagnostic apparatus for measuring an individual's genetic drug compatibility for use in determining an individual's genetic variability on his or her response to certain drugs for the purpose of identifying the most effective drugs, applying the best doses and optimal concentrations of these drugs, avoiding undesirable side effects according to the genetic pattern of each individual; Medical diagnostic apparatus for measuring an individual's genetic personality traits; Medical diagnostic apparatus for measuring an individual's genetic predisposition to well-being-related data, namely the individual's genetic predisposition to their body's response to food and exercise; Medical diagnostic apparatus for measuring an individual's genetic ancestry, namely the individual's paternal and maternal haplogroups, the percentage of Neanderthal DNA in the individual's genetic makeup, and ethnic origin of the ind...

Providing scientific analysis and informational reports based upon results of laboratory testing in the field of genetics; providing online computer databases featuring scientific information based on aggregated results of genotyping; application service provider (asp) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service provider (asp) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of genetics and genetic testing; scientific research in the fields of genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, and ancestry; Consulting services in the fields of biotechnology and pharmaceutical research and development; providing information about medical and scientific research; development of non-downloadable computer software for scientific analysis of genetic seq...
tellmegen

General Information


Serial Number97761526
Word MarkTELLMEGEN
Filing DateThursday, January 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "tellmeGen" in dark gray. Above the wording, there are a pattern of colored squares. In the top line, there is a yellow, white, and pink square. In the next line, there is a light turquoise, red, light blue, black, and light gray square. In the next line, there is a dark turquoise, brown, light orange, and dark orange square. In the next line, there is a dark green, purple, and aqua blue square. In the last line is a dark blue square.
Pseudo MarkTELL ME GEN
Indication of Colors claimedThe color(s) light green, pink, white, dark gray, yellow, light turquoise, red, light blue, black, light gray, dark turquoise, brown, light orange, dark orange, dark green, purple, aqua blue, and dark blue is/are claimed as a feature of the mark.
Goods and ServicesMedical diagnostic apparatus for measuring genetic predisposition to diseases; Medical diagnostic apparatus for measuring an individual's genetic drug compatibility for use in determining an individual's genetic variability on his or her response to certain drugs for the purpose of identifying the most effective drugs, applying the best doses and optimal concentrations of these drugs, avoiding undesirable side effects according to the genetic pattern of each individual; Medical diagnostic apparatus for measuring an individual's genetic personality traits; Medical diagnostic apparatus for measuring an individual's genetic predisposition to well-being-related data, namely the individual's genetic predisposition to their body's response to food and exercise; Medical diagnostic apparatus for measuring an individual's genetic ancestry, namely the individual's paternal and maternal haplogroups, the percentage of Neanderthal DNA in the individual's genetic makeup, and ethnic origin of the individual's ancestors; Medical diagnostic apparatus for testing DNA samples; Kits for use in genetic identity testing and genetic diagnostic testing for medical purposes comprising a saliva collection tube, saliva collection swabs, printed instructions, and mailing packaging for use in DNA testing of humans
Goods and ServicesProviding scientific analysis and informational reports based upon results of laboratory testing in the field of genetics; providing online computer databases featuring scientific information based on aggregated results of genotyping; application service provider (asp) featuring software for providing access to multiple databases that contain aggregated results of genotyping; application service provider (asp) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of genetics and genetic testing; scientific research in the fields of genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, and ancestry; Consulting services in the fields of biotechnology and pharmaceutical research and development; providing information about medical and scientific research; development of non-downloadable computer software for scientific analysis of genetic sequences

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENELINK, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressValencia 46010
ES

Party NameGENELINK, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressValencia 46010
ES

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Monday, January 23, 2023NEW APPLICATION ENTERED
Thursday, February 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, October 20, 2023NON-FINAL ACTION WRITTEN
Friday, October 20, 2023NON-FINAL ACTION E-MAILED
Friday, October 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 24, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL